ASCO-contributor/ Market Access/ Oncology/ Partner content/ Partner Content/ Partner Content/ Pharma Market Access/ Press releases Further Darzalex results extend hope for PFS in Myeloma Greg Wolfe and Jay Grisolano asco, Darzalex. CASTOR, kantar health, myeloma, Oncology, pharma 0 Comment Earlier this year (March), Johnson & Johnson announced that the randomized Phase III CASTOR trial (NCT02136134) achieved its Share X Further Darzalex results extend hope for PFS in Myeloma https://pharmaphorum.com/partner-content-oncology/further-darzalex-results-extend-hope-for-pfs-in-myeloma/
asco, Darzalex. CASTOR, kantar health, myeloma, Oncology, pharma
0 Comment
